EMEA-000637-PIP02-10-M06

Key facts

Invented name
Fosrenol and associated names
Active substance
Lanthanum carbonate hydrate
Therapeutic area
Uro-nephrology
Decision number
P/0303/2018
PIP number
EMEA-000637-PIP02-10-M06
Pharmaceutical form(s)
  • Chewable tablet
  • Oral powder
Condition(s) / indication(s)
Treatment of hyperphosphataemia
Route(s) of administration
Oral use
Contact for public enquiries
Takeda Pharmaceuticals International AG Ireland Branch

E-mail: medinfoemea@takeda.com
Tel: +44 (0) 3333 000181

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating